Suchergebnisse - "Diamond, Jennifer R"

PubPharm (123)

1

Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis

enthalten in: Breast cancer research : BCR | 2024

von Smoots, S. | Schreiber, A. | Jackson, M. | +8

2

Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors

enthalten in: Journal for immunotherapy of cancer | 2024

von Patel, S. | Alonso-Gordoa, T. | Banerjee, S. | +11

3

Major cardiovascular adverse events in older adults with early-stage triple-negative breast cancer treated with adjuvant taxane + anthracycline versus taxane-based chemotherapy regimens : A SEER-medicare study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Roy, S. | Lakritz, S. | Schreiber, A. | +4

4

First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors

enthalten in: Cancers | 2023

von Schreiber, A. | Kagihara, J. | Corr, B. | +16

5

Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Shagisultanova, E. | Gradishar, W. | Brown-Glaberman, U. | +10

CommentIn: Clin Cancer Res. 2023 Dec 15;29(24):4993-4995. - PMID 37782311

6

The emergence of targeted therapy for HER2-low triple-negative breast cancer : a review of fam-trastuzumab deruxtecan

enthalten in: Expert review of anticancer therapy | 2023

von Schreiber, A. | O'Bryant, C. | Kabos, P. | +1

7

Exceptional Response to Bromodomain and Extraterminal Domain Inhibitor Therapy With BMS-986158 in BRD4-NUTM1 NUT Carcinoma Harboring a BRD4 Splice Site Mutation

enthalten in: JCO precision oncology | 2023

von Cheng, M. | Huang, Y. | Luong, N. | +12

8

Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer

enthalten in: NPJ breast cancer | 2023

von Elias, A. | Spoelstra, N. | Staley, A. | +20

9

Clinical outcomes of adjuvant taxane plus anthracycline versus taxane-based chemotherapy regimens in older adults with node-positive, triple-negative breast cancer : A SEER-Medicare study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Roy, S. | Lakritz, S. | Schreiber, A. | +7

10

ATM kinase inhibitor AZD0156 in combination with irinotecan and 5-fluorouracil in preclinical models of colorectal cancer

enthalten in: BMC cancer | 2022

von Davis, S. | Hartman, S. | Bagby, S. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]